Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Di Giambenedetto S

Collect these papers and discover other ones on Labmeeting. Learn more.

Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar years: A cohort study.

+ cite this

+ View Abstract

Bracciale L, Fanti I, Di Giambenedetto S, Colafigli M, Prosperi M, Bacarelli A, Santangelo R, Cattani P, Cauda R, and De Luca A

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 46(3):290-4, 2009 Nov - Who cited this? | PubMed ID: 19699675 | Fulltext

Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study.

+ cite this

+ View Abstract

Di Giambenedetto S, Torti C, Prosperi M, Manca N, Lapadula G, Paraninfo G, Ladisa N, Zazzi M, Trezzi M, Cicconi P, Corsi P, Nasta P, Cauda R, De Luca A, UCSC cohort, MASTER cohort,

(show remaining authors)

Infection 37(5):438-44, 2009 Oct - Who cited this? | PubMed ID: 19669091 | Fulltext

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.

+ cite this

+ View Abstract

Bracciale L, Colafigli M, Zazzi M, Corsi P, Meraviglia P, Micheli V, Maserati R, Gianotti N, Penco G, Setti M, Di Giambenedetto S, Butini L, Vivarelli A, Trezzi M, and De Luca A

The Journal of antimicrobial chemotherapy 64(3):607-15, 2009 Sep - Who cited this? | PubMed ID: 19608581 | Fulltext

Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.

+ cite this

+ View Abstract

Zazzi M, Prosperi M, Vicenti I, Di Giambenedetto S, Callegaro A, Bruzzone B, Baldanti F, Gonnelli A, Boeri E, Paolini E, Rusconi S, Giacometti A, Maggiolo F, Menzo S, De Luca A, and ARCA Collaborative Group

The Journal of antimicrobial chemotherapy 64(3):616-24, 2009 Sep - Who cited this? | PubMed ID: 19620134 | Fulltext

Long-term follow-up of nevirapine-treated patients in a single-centre cohort.

+ cite this

+ View Abstract

Colafigli M, Di Giambenedetto S, Bracciale L, Fanti I, Prosperi M, Cauda R, and De Luca A

HIV medicine 10(8):461-9, 2009 Sep - Who cited this? | PubMed ID: 19459991 | Fulltext

Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.

+ cite this

+ View Abstract

Fabbiani M, Di Giambenedetto S, Bracciale L, Bacarelli A, Ragazzoni E, Cauda R, Navarra P, and De Luca A

The Journal of antimicrobial chemotherapy 64(1):109-17, 2009 Jul - Who cited this? | PubMed ID: 19398461 | Fulltext

Virological Suppression Reduces Clinical Progression in Patients with Multiclass-Resistant HIV Type 1.

+ cite this

+ View Abstract

Bracciale L, Di Giambenedetto S, Colafigli M, La Torre G, Prosperi M, Santangelo R, Marchetti S, Cauda R, Fadda G, and De Luca A

AIDS research and human retroviruses 25(3):261-7, 2009 Mar - Who cited this? | PubMed ID: 19292594 | Fulltext

Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction?.

+ cite this

+ View Abstract

Bracciale L, Santangelo R, Fanti I, Prosperi M, Colafigli M, Di Giambenedetto S, Marchetti S, Di Franco A, Cauda R, and De Luca A

Antiviral therapy 14(1):99-101, 2009 - Who cited this? | PubMed ID: 19320242 | Fulltext

Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.

+ cite this

+ View Abstract

Di Giambenedetto S, Zazzi M, Corsi P, Gonnelli A, Di Pietro M, Giacometti A, Almi P, Trezzi M, Boeri E, Gianotti N, Menzo S, Del Gobbo R, Francisci D, Nerli A, Galli L, De Luca A,

(show remaining authors)

Antiviral therapy 14(3):359-69, 2009 - Who cited this? | PubMed ID: 19474470 | Fulltext

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.

+ cite this

+ View Abstract

De Luca A, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J, Di Giambenedetto S, Cingolani A, Taoufik Y, Miralles P, Marra CM, Antinori A, and

AIDS (London, England) 22(14):1759, 2008 Sep 12 - Who cited this? | PubMed ID: 18753934 | Fulltext

Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure.

+ cite this

+ View Abstract

Di Giambenedetto S, De Luca A, Villani P, Bacarelli A, Ragazzoni E, Regazzi M, Cauda R, and Navarra P

HIV medicine 9(4):239-45, 2008 Apr - Who cited this? | PubMed ID: 18366448 | Fulltext

Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.

+ cite this

+ View Abstract

Colafigli M, Di Giambenedetto S, Bracciale L, Tamburrini E, Cauda R, and De Luca A

HIV medicine 9(3):172-9, 2008 Mar - Who cited this? | PubMed ID: 18217998 | Fulltext

Genotypic Resistance Profile and Clinical Progression of Treatment-Experienced HIV Type 1-Infected Patients with Virological Failure.

+ cite this

+ View Abstract

Di Giambenedetto S, Colafigli M, Pinnetti C, Bacarelli A, Cingolani A, Tamburrini E, Cauda R, and de Luca A

AIDS research and human retroviruses 24(2):149-54, 2008 Feb - Who cited this? | PubMed ID: 18240962 | Fulltext

Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.

+ cite this

+ View Abstract

De Luca A, Weidler J, Di Giambenedetto S, Coakley E, Cingolani A, Bates M, Lie Y, Pesano R, Cauda R, and Schapiro J

Journal of acquired immune deficiency syndromes (1999) 45(4):411-7, 2007 Aug 1 - Who cited this? | PubMed ID: 17554216 | Fulltext

Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.

+ cite this

+ View Abstract

Torti C, Lapadula G, Uccelli MC, Quiros-Roldan E, Regazzi M, Ladisa N, Micheli V, Orani A, Patroni A, Caputo SL, Tirelli V, Di Giambenedetto S, Cologni G, Costarelli S, Gargiulo F, Manca N,

(show remaining authors)

International journal of antimicrobial agents 29(2):185-90, 2007 Feb - Who cited this? | PubMed ID: 17011754 | Fulltext

Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy.

+ cite this

+ View Abstract

Quiros-Roldan E, Torti C, Lapadula G, Ladisa N, Micheli V, Patroni A, Cusato M, Pierotti P, Tirelli V, Uccelli MC, Di Giambenedetto S, Castelnuovo F, Gargiulo F, Manca N, Carosi G, and RADAR-Master Study Group

AIDS patient care and STDs 21(2):92-9, 2007 Feb - Who cited this? | PubMed ID: 17328658 | Fulltext

Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.

+ cite this

+ View Abstract

Di Giambenedetto S, Brocciale L, Colafigli M, Cattani P, Pinnetti C, Bacarelli A, Prosperi M, Fadda G, Cauda R, and De Luca A

Antiviral therapy 12(5):835-9, 2007 - Who cited this? | PubMed ID: 17713168 | Fulltext

Genotypic resistance to lopinavir and fosamprenavir with or without ritonavir of clinical isolates from patients failing protease inhibitors-containing HAART regimens: prevalence and predictors.

+ cite this

+ View Abstract

Di Giambenedetto S, Bacarelli A, Pinnetti C, Colafigli M, Prosperi M, Gatti G, Cauda R, and De Luca A

Scandinavian journal of infectious diseases 39(9):813-8, 2007 - Who cited this? | PubMed ID: 17701721 | Fulltext

A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads.

+ cite this

+ View Abstract

Cozzi-Lepri A, De Luca A, Phillips AN, Bongiovanni M, Di Giambenedetto S, Mena M, Moioli MC, Arlotti M, Sighinolfi L, Narciso P, Lichtner M, Cauda R, Monforte A, , , and

The Journal of infectious diseases 194(1):20, 2006 Jul 1 - Who cited this? | PubMed ID: 16741878 | Fulltext

Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy.

+ cite this

+ View Abstract

De Luca A, Di Giambenedetto S, Romano L, Gonnelli A, Corsi P, Baldari M, Di Pietro M, Menzo S, Francisci D, Almi P, Zazzi M, and

The Journal of infectious diseases 193(9):1219-22, 2006 May 1 - Who cited this? | PubMed ID: 16586357 | Fulltext

Three-year clinical outcomes of resistance genotyping and expert advice: extended follow-up of the Argenta trial.

+ cite this

+ View Abstract

De Luca A, Di Giambenedetto S, Cingolani A, Bacarelli A, Ammassari A, and Cauda R

Antiviral therapy 11(3):321-7, 2006 - Who cited this? | PubMed ID: 16759048 | Fulltext

Lopinavir/ritonavir or efavirenz plus two nucleoside analogues as first-line antiretroviral therapy: a non-randomized comparison.

+ cite this

+ View Abstract

De Luca A, Cozzi-Lepri A, Antinori A, Zaccarelli M, Bongiovanni M, Di Giambenedetto S, Marconi P, Cicconi P, Resta F, Grisorio B, Ciardi M, Cauda R, Monforte A, I.Co.N.A, UCSC, IMIT-MI,

(show remaining authors)

Antiviral therapy 11(5):609-18, 2006 - Who cited this? | PubMed ID: 16964829 | Fulltext

Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy.

+ cite this

+ View Abstract

Marzocchetti A, Di Giambenedetto S, Cingolani A, Ammassari A, Cauda R, and De Luca A

Journal of clinical microbiology 43(8):4175-7, 2005 Aug - Who cited this? | PubMed ID: 16081969 | Fulltext

A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study.

+ cite this

+ View Abstract

Torti C, Quiros-Roldan E, Regazzi M, De Luca A, Mazzotta F, Antinori A, Ladisa N, Micheli V, Orani A, Patroni A, Villani P, Lo Caputo S, Moretti F, Di Giambenedetto S, Castelnuovo F, Maggi P,

(show remaining authors)

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 40(12):1828-36, 2005 Jun 15 - Who cited this? | PubMed ID: 15909273 | Fulltext

CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l.

+ cite this

+ View Abstract

Mussini C, Bedini A, Borghi V, Guaraldi G, Esposito R, Barchi E, Enilia R, Cozzi-Lepri A, Philips AN, Ortolani P, Bratt G, Eriksson LE, Sighinolfi L, Cossarizza A, d'Arminio Monforte A, De Luca A,

(show remaining authors)

AIDS (London, England) 19(3):287-94, 2005 Feb 18 - Who cited this? | PubMed ID: 15718839 | Fulltext

Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?.

+ cite this

Di Giambenedetto S, Vago G, Pompucci A, Scoppettuolo G, Cingolani A, Marzocchetti A, Tumbarello M, Cauda R, and De Luca A

Neurology 63(12):2452-3, 2004 Dec 28 - Who cited this? | PubMed ID: 15623736 | Fulltext

Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems.

+ cite this

+ View Abstract

De Luca A, Cozzi-Lepri A, Perno CF, Balotta C, Di Giambenedetto S, Poggio A, Pagano G, Tositti G, Piscopo R, Del Forno A, Chiodo F, Magnani G, d'Arminio Monforte A, ICoNA drug resistance study group, and ICoNA study group

Antiviral therapy 9(5):743-52, 2004 Oct - Who cited this? | PubMed ID: 15535412 | Fulltext

Triple-nucleoside regimens versus efavirenz.

+ cite this

De Luca A and Di Giambenedetto S

The New England journal of medicine 351(7):717-9; author reply 717-9, 2004 Aug 12 - Who cited this? | PubMed ID: 15306677 | Fulltext

Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.

+ cite this

+ View Abstract

De Luca A, Vendittelli M, Baldini F, Di Giambenedetto S, Trotta MP, Cingolani A, Bacarelli A, Gori C, Perno CF, Antinori A, and Ulivi G

Antiviral therapy 9(4):583-93, 2004 Aug - Who cited this? | PubMed ID: 15456090 | Fulltext

Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients.

+ cite this

+ View Abstract

De Luca A, Di Giambenedetto S, Cingolani A, Ammassari A, Marasca G, Tumbarello M, Fantoni M, Tamburrini E, and Cauda R

AIDS (London, England) 18(11):1602-4, 2004 Jul 23 - Who cited this? | PubMed ID: 15238782 | Fulltext

The influence of hepatitis C virus coinfection on the risk of lipid abnormalities in a cohort of HIV-1-infected patients after initiation of highly active antiretroviral therapy.

+ cite this

Di Giambenedetto S, Baldini F, Cingolani A, Tamburrini E, Cauda R, and De Luca A

Journal of acquired immune deficiency syndromes (1999) 36(1):641-2, 2004 May 1 - Who cited this? | PubMed ID: 15097310 | Fulltext

Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics.

+ cite this

+ View Abstract

De Luca A, Baldini F, Cingolani A, Di Giambenedetto S, Hoetelmans RM, and Cauda R

Journal of acquired immune deficiency syndromes (1999) 35(4):359-66, 2004 Apr 1 - Who cited this? | PubMed ID: 15097152 | Fulltext

Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations.

+ cite this

Torti C, Quiros-Roldan E, Regazzi-Bonora M, De Luca A, Lo Caputo S, Di Giambenedetto S, Patroni A, Villani P, Micheli V, Carosi G, and Resistance and Dosage Adapted Regimens Study Group of the MASTER Cohort

Journal of acquired immune deficiency syndromes (1999) 35(3):324-6, 2004 Mar 1 - Who cited this? | PubMed ID: 15076251 | Fulltext

Interpretation systems for genotypic drug resistance of HIV-1.

+ cite this

+ View Abstract

De Luca A, Antinori A, Di Giambenedetto S, Cingolani A, Colafigli M, Perno CF, and Cauda R

Scandinavian journal of infectious diseases. Supplementum 35 Suppl 106:29-34, 2003 Dec - Who cited this? | PubMed ID: 15000579 | Fulltext

Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.

+ cite this

+ View Abstract

De Luca A, Cingolani A, Di Giambenedetto S, Trotta MP, Baldini F, Rizzo MG, Bertoli A, Liuzzi G, Narciso P, Murri R, Ammassari A, Perno CF, and Antinori A

The Journal of infectious diseases 187(12):1934-43, 2003 Jun 15 - Who cited this? | PubMed ID: 12792870 | Fulltext

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

+ cite this

+ View Abstract

Zaccarelli M, Perno CF, Forbici F, Cingolani A, Liuzzi G, Bertoli A, Trotta MP, Bellocchi MC, Di Giambenedetto S, Tozzi V, Gori C, D'Arrigo R, De Longis P, Noto P, Girardi E, De Luca A,

(show remaining authors)

Antiviral therapy 8(1):51-6, 2003 Feb - Who cited this? | PubMed ID: 12713064 | Fulltext

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.

+ cite this

+ View Abstract

Antinori A, Zaccarelli M, Cingolani A, Forbici F, Rizzo MG, Trotta MP, Di Giambenedetto S, Narciso P, Ammassari A, Girardi E, De Luca A, and Perno CF

AIDS research and human retroviruses 18(12):835-8, 2002 Aug 10 - Who cited this? | PubMed ID: 12201905 | Fulltext

Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy.

+ cite this

Gillini LA, Cingolani A, Murri R, De Luca A, Di Giambenedetto S, Wu A, Cauda R, and Chaisson RE

Journal of acquired immune deficiency syndromes (1999) 29(5):546-7, 2002 Apr 15 - Who cited this? | PubMed ID: 11981374 | Fulltext

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

+ cite this

+ View Abstract

Cingolani A, Antinori A, Rizzo MG, Murri R, Ammassari A, Baldini F, Di Giambenedetto S, Cauda R, and De Luca A

AIDS (London, England) 16(3):369-79, 2002 Feb 15 - Who cited this? | PubMed ID: 11834948 | Fulltext

Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy.

+ cite this

Antinori A, Liuzzi G, Cingolani A, Bertoli A, Di Giambenedetto S, Trotta MP, Rizzo MG, Girardi E, De Luca A, and Perno CF

AIDS (London, England) 15(17):2325-7, 2001 Nov 23 - Who cited this? | PubMed ID: 11698709 | Fulltext

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.

+ cite this

+ View Abstract

Antinori A, Baldini F, Girardi E, Cingolani A, Zaccarelli M, Di Giambenedetto S, Barracchini A, De Longis P, Murri R, Tozzi V, Ammassari A, Rizzo MG, Ippolito G, and De Luca A

AIDS (London, England) 15(12):1579-81, 2001 Aug 17 - Who cited this? | PubMed ID: 11504993 | Fulltext

Benefits and risks of switching from protease inhibitors to nevirapine with stable background therapy in patients with low or undetectable viral load: a multicentre study.

+ cite this

De Luca A, Baldini F, Cingolani A, Di Giambenedetto S, Zaccarelli M, Tozzi V, Ammassari A, Murri R, and Antinori A

AIDS (London, England) 14(11):1655-6, 2000 Jul 28 - Who cited this? | PubMed ID: 10983653 | Fulltext

Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.

+ cite this

Baldini F, Di Giambenedetto S, Cingolani A, Murri R, Ammassari A, and De Luca A

AIDS (London, England) 14(11):1660-2, 2000 Jul 28 - Who cited this? | PubMed ID: 10983656 | Fulltext

Search Google Scholar for Di Giambenedetto S

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.